Guardant Health Q2 Adjusted EPS USD -0.42 Vs. IBES Estimate USD -0.41
GH•Q2 results and outlook
Jul 30 (Reuters) - Guardant Health Q2 revenue USD 335 million vs. IBES estimate USD 314.2 million.
- Q2 EPS USD -0.9
- Q2 adjusted net income USD -56.2 million vs. IBES estimate USD -54.3 million
- Q2 adjusted EBITDA USD -55.9 million vs. IBES estimate USD -50.3 million
- outlook FY revenue USD 1,340-1,360 million vs. IBES estimate USD 1,314 million




